Legend Biotech Corporation
LEGN
$35.64
-$0.27-0.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -100.92M | 26.28M | -125.32M | -18.20M | -59.79M |
| Total Depreciation and Amortization | 5.20M | 6.59M | 5.16M | 5.00M | 5.72M |
| Total Amortization of Deferred Charges | -- | 206.00K | 314.00K | 366.00K | -- |
| Total Other Non-Cash Items | 65.55M | -35.08M | 61.42M | -189.00K | -24.46M |
| Change in Net Operating Assets | -73.59M | -80.08M | -17.39M | 11.37M | 94.05M |
| Cash from Operations | -103.75M | -82.08M | -75.82M | -1.65M | 15.52M |
| Capital Expenditure | -2.00M | -2.38M | -2.07M | -3.42M | -6.25M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 258.64M | -85.46M | 331.14M | -692.21M | -389.90M |
| Cash from Investing | 256.64M | -87.84M | 329.08M | -695.63M | -396.15M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -777.00K | -936.00K | -1.16M | -1.16M | -758.00K |
| Issuance of Common Stock | 1.44M | 603.00K | 5.41M | 2.12M | 1.59M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 667.00K | -333.00K | 4.25M | 955.00K | 831.00K |
| Foreign Exchange rate Adjustments | 1.40M | -2.28M | 524.00K | 9.00K | -343.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 154.95M | -172.53M | 258.02M | -696.32M | -380.14M |